Coronavirus — India Hopes for Vaccine by August

  • Human testing of the vaccine would start from July 7.
  • A total of 12 medical institutions have been asked by the ICMR to expedite the clinical trial of the vaccine.
  • Zydus Cadila is the second company in the country to get human testing permission.

A Coronavirus vaccine has been developed in India, and is scheduled to launch on August 15. Hyderabad-based pharmaceutical company Bharat Biotech is preparing to launch it. The Indian Council of Medical Research (ICMR) has directed to complete the clinical trial in the meantime.

Bharat Biotech Limited or Bharat Biotech International Limited is a Pharmaceuticals company headquartered at Hyderabad, India engaged in manufacturing vaccines, bio-therapeutics and health care products. On June 29, the company got permission to conduct human trials of developmental COVID-19 vaccine named Covaxin, from DCGI, Government of India after successful phase-I and II clinical trials.

The vaccine was reportedly developed jointly by the two entities. Notably, only a few days ago, the company was allowed to carry out a human trial of its vaccine.

Plan to Launch on August 15th

Dr. Balram Bhargava, Director General of the ICMR, said in a departmental letter that human testing of the vaccine would start from July 7, and should not be delayed so that the vaccine could be launched to the public on August 15.

“This is the first indigenous vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the Government,” said Bhargava.

“The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National lnstitute of Virology, Pune” He added, “ICMR and BBIL [Bharat Biotech International] are jointly working for the preclinical as well as clinical development of this vaccine.”

A total of 12 medical institutions have been asked by the ICMR to expedite the clinical trial of the vaccine. In the letter, Dr. Bhargava wrote to these organizations:

“You have been chosen as a clinical trial site of the BBV152 COVID Vaccine. In view of the public health emergency due to COVID-19 pandemic and urgency, to launch the vaccine, you are strictly advised to fast track all approvals related to the initiation of the clinical trial and ensure that the subject enrollment is initiated no later than 7, July 2020.”

Bharat Biotech’s “Covacin”

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID‑19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

India Biotech and ICMR are partners in developing this vaccine, called “covacin.” According to information provided on Bharat Biotech’s site, the vaccine is India’s first indigenous COVID-19 vaccine.

According to the company, the vaccine has been developed in collaboration with the ICMR-National Institute of Virology. It has been developed into Bharat Biotech’s BSL-3 (Biosafety Level-3) High Containment Facility.

The company also said it had received approval for the first phase of the vaccine trial and the second phase of human testing. Tests will be conducted across the country in July.

The pharmaceutical company Zydus Cadila has been given permission by the Drug Controller of India (DCGI) to conduct human tests in the first and second phases of the coronavirus vaccine. Zydus Cadila is the second company in the country to get human testing permission.

Business Insider quotes sources close to the research as saying that the research on animals has been successful. Following this, the company was approached by Dr. of DCGI to make a vaccine for the virus. VG Somani has given permission for the first and second phase trials. “It will take two to three months to complete the first and second phase trials,” the company said.

Only $1/click

Submit Your Ad Here

Joyce Davis

My history goes back to 2002 and I  worked as a reporter, interviewer, news editor, copy editor, managing editor, newsletter founder, almanac profiler, and news radio broadcaster.

Leave a Reply